Cytomx Therapeutics Stock Market Value

CTMX Stock  USD 2.19  0.08  3.79%   
CytomX Therapeutics' market value is the price at which a share of CytomX Therapeutics trades on a public exchange. It measures the collective expectations of CytomX Therapeutics investors about its performance. CytomX Therapeutics is trading at 2.19 as of the 28th of March 2024; that is 3.79% increase since the beginning of the trading day. The stock's open price was 2.11.
With this module, you can estimate the performance of a buy and hold strategy of CytomX Therapeutics and determine expected loss or profit from investing in CytomX Therapeutics over a given investment horizon. Check out CytomX Therapeutics Correlation, CytomX Therapeutics Volatility and CytomX Therapeutics Alpha and Beta module to complement your research on CytomX Therapeutics.
For more information on how to buy CytomX Stock please use our How to Invest in CytomX Therapeutics guide.
Symbol

CytomX Therapeutics Price To Book Ratio

Is CytomX Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CytomX Therapeutics. If investors know CytomX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CytomX Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.01)
Revenue Per Share
1.371
Quarterly Revenue Growth
0.322
Return On Assets
(0.02)
Return On Equity
(54.75)
The market value of CytomX Therapeutics is measured differently than its book value, which is the value of CytomX that is recorded on the company's balance sheet. Investors also form their own opinion of CytomX Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is CytomX Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CytomX Therapeutics' market value can be influenced by many factors that don't directly affect CytomX Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CytomX Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if CytomX Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CytomX Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

CytomX Therapeutics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CytomX Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CytomX Therapeutics.
0.00
02/02/2023
No Change 0.00  0.0 
In 1 year 1 month and 25 days
03/28/2024
0.00
If you would invest  0.00  in CytomX Therapeutics on February 2, 2023 and sell it all today you would earn a total of 0.00 from holding CytomX Therapeutics or generate 0.0% return on investment in CytomX Therapeutics over 420 days. CytomX Therapeutics is related to or competes with Agilent Technologies, and Mediwound. CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States More

CytomX Therapeutics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CytomX Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CytomX Therapeutics upside and downside potential and time the market with a certain degree of confidence.

CytomX Therapeutics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for CytomX Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CytomX Therapeutics' standard deviation. In reality, there are many statistical measures that can use CytomX Therapeutics historical prices to predict the future CytomX Therapeutics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CytomX Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.112.188.57
Details
Intrinsic
Valuation
LowRealHigh
0.112.148.53
Details
Naive
Forecast
LowNextHigh
0.041.988.37
Details
7 Analysts
Consensus
LowTargetHigh
2.272.492.76
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as CytomX Therapeutics. Your research has to be compared to or analyzed against CytomX Therapeutics' peers to derive any actionable benefits. When done correctly, CytomX Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in CytomX Therapeutics.

CytomX Therapeutics Backtested Returns

CytomX Therapeutics appears to be dangerous, given 3 months investment horizon. CytomX Therapeutics secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12% return per unit of risk over the last 3 months. By analyzing CytomX Therapeutics' technical indicators, you can evaluate if the expected return of 0.75% is justified by implied risk. Please makes use of CytomX Therapeutics' Mean Deviation of 3.74, risk adjusted performance of 0.0864, and Downside Deviation of 4.29 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, CytomX Therapeutics holds a performance score of 9. The firm shows a Beta (market volatility) of -0.91, which signifies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning CytomX Therapeutics are expected to decrease slowly. On the other hand, during market turmoil, CytomX Therapeutics is expected to outperform it slightly. Please check CytomX Therapeutics' potential upside, as well as the relationship between the accumulation distribution and period momentum indicator , to make a quick decision on whether CytomX Therapeutics' price patterns will revert.

Auto-correlation

    
  -0.29  

Weak reverse predictability

CytomX Therapeutics has weak reverse predictability. Overlapping area represents the amount of predictability between CytomX Therapeutics time series from 2nd of February 2023 to 31st of August 2023 and 31st of August 2023 to 28th of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CytomX Therapeutics price movement. The serial correlation of -0.29 indicates that nearly 29.0% of current CytomX Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient-0.29
Spearman Rank Test-0.43
Residual Average0.0
Price Variance0.14

CytomX Therapeutics lagged returns against current returns

Autocorrelation, which is CytomX Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CytomX Therapeutics' stock expected returns. We can calculate the autocorrelation of CytomX Therapeutics returns to help us make a trade decision. For example, suppose you find that CytomX Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

CytomX Therapeutics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CytomX Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CytomX Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CytomX Therapeutics stock over time.
   Current vs Lagged Prices   
       Timeline  

CytomX Therapeutics Lagged Returns

When evaluating CytomX Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CytomX Therapeutics stock have on its future price. CytomX Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CytomX Therapeutics autocorrelation shows the relationship between CytomX Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in CytomX Therapeutics.
   Regressed Prices   
       Timeline  

CytomX Therapeutics Investors Sentiment

The influence of CytomX Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in CytomX. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to CytomX Therapeutics' public news can be used to forecast risks associated with an investment in CytomX. The trend in average sentiment can be used to explain how an investor holding CytomX can time the market purely based on public headlines and social activities around CytomX Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
CytomX Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for CytomX Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average CytomX Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on CytomX Therapeutics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards CytomX Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, CytomX Therapeutics' short interest history, or implied volatility extrapolated from CytomX Therapeutics options trading.

Pair Trading with CytomX Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CytomX Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with CytomX Stock

  0.67MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
  0.61EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against CytomX Stock

  0.85KA Kineta Inc Report 29th of March 2024 PairCorr
  0.81TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
  0.61MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.57VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.52MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to CytomX Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CytomX Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CytomX Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CytomX Therapeutics to buy it.
The correlation of CytomX Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CytomX Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CytomX Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CytomX Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether CytomX Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CytomX Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytomx Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytomx Therapeutics Stock:
Check out CytomX Therapeutics Correlation, CytomX Therapeutics Volatility and CytomX Therapeutics Alpha and Beta module to complement your research on CytomX Therapeutics.
For more information on how to buy CytomX Stock please use our How to Invest in CytomX Therapeutics guide.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Complementary Tools for CytomX Stock analysis

When running CytomX Therapeutics' price analysis, check to measure CytomX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CytomX Therapeutics is operating at the current time. Most of CytomX Therapeutics' value examination focuses on studying past and present price action to predict the probability of CytomX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CytomX Therapeutics' price. Additionally, you may evaluate how the addition of CytomX Therapeutics to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Fundamental Analysis
View fundamental data based on most recent published financial statements
CytomX Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of CytomX Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of CytomX Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...